Latest Mergers And Acquisitions News

Melbana Energy reports steady progress on its Cuban Block 9 project, including an imminent workover of Alameda-2 and upcoming drilling of Amistad-2, supported by a solid cash position of $9.7 million.

IPB Petroleum has appointed a new chairman and is intensifying efforts to secure funding for drilling its key Browse Basin assets, while maintaining a strong cash position and exploring new project opportunities.

G50 Corp has advanced its exploration efforts with new drilling campaigns targeting high-grade silver, gold, and gallium at its Golconda Project in Arizona and White Caps Project in Nevada, supported by a recent A$5.6 million capital raise.

Memphasys Limited marks a pivotal quarter with the completion of clinical trials for its Felix™ System, strategic market expansions in Greater China and the Middle East, and a successful capital raise to fuel growth.

Connected Minerals Ltd has successfully raised $5.1 million to fuel its aggressive uranium exploration in Namibia, reporting impressive high-grade rock chip results that set the stage for maiden drilling in early 2025.

Peregrine Gold secures a significant $1 million commitment from its largest shareholder, Yandal Investments, strengthening its entitlement offer ahead of the project sale to Capricorn Metals.

Discovery Alaska Limited is actively assessing new project opportunities and reviewing strategies for its key Alaskan gold assets, while maintaining cautious financial management with limited cash reserves.

Falcon Metals reports steady progress across its Victorian and Western Australian projects, maintaining a strong cash position to fuel ongoing exploration in 2025.

Godolphin Resources reports significant drilling success at Lewis Ponds with thick massive sulphide intersections and advances its Narraburra Rare Earths project with high-value carbonate samples, supported by a strong capital raise.

Neometals Ltd has bolstered its financial position with a A$7.1 million capital raise while progressing key projects including the commissioning of a lithium-ion battery recycling plant in Germany and preparing for maiden gold drilling at Barrambie.

InhalerX Limited reported a negative cash flow for the December quarter despite securing a substantial $38.5 million funding facility aimed at advancing its clinical trials. The company has yet to draw on this facility, maintaining a cautious cash position as it progresses its drug development programs.

InhaleRx has locked in a $38.5 million funding deal with Clendon Biotech Capital, enabling expanded Phase 2 trials for its inhaled breakthrough cancer pain and panic disorder treatments. The company also filed a key international patent, positioning itself for a faster path to FDA approval.